We are live on ! Find out more
RCPI

Rock Creek Pharmaceuticals
RCPI

Delisted

RCPI was delisted on the 4th of November, 2015.

77 hedge funds and large institutions have $13.8M invested in Rock Creek Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 77 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

950% more call options, than puts

Call options by funds: $2.39M | Put options by funds: $228K

Holders
77
Holders Change
+77
Holders Change %
–
% of All Funds
2.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
77
Increased
–
Reduced
–
Closed
–
Calls
$2.39​M
Puts
$228​K
Net Calls
+$2.17​M
Net Calls Change
+$2.17​M

RCPI Hedge Fund Activity: Q2 2014 in Review

77 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Rock Creek Pharmaceuticals (RCPI) for Q2 2014, worth a combined $13.8M.

Buyers outnumbered sellers: 77 funds opened new RCPI positions and 0 closed out — a net gain of 77 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Goldman Capital Management, opening a new position worth an estimated $3.89M.

  • 77 institutional investors held Rock Creek Pharmaceuticals (RCPI) as of Q2 2014, up from 0 in Q1 2014.
  • Funds reported $13.8M of Rock Creek Pharmaceuticals stock for Q2 2014.
  • 77 funds opened new Rock Creek Pharmaceuticals positions in Q2 2014 and 0 closed out, a net change of +77 holders.
  • The largest Rock Creek Pharmaceuticals buyer in Q2 2014 was Goldman Capital Management, an estimated $3.89M added.

Based on aggregated 13F filings for Q2 2014.